Standout Papers
- Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells (2008)
- CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results (2012)
Immediate Impact
5 by Nobel laureates 26 from Science/Nature 269 standout
Citing Papers
CAR T therapy beyond cancer: the evolution of a living drug
2023 StandoutNature
CAR T cell killing requires the IFNγR pathway in solid but not liquid tumours
2022 StandoutNature
Works of Jinjuan Wang being referenced
Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells
2008 Standout
Optimizing Adoptive Polyclonal T Cell Immunotherapy of Lymphomas, Using a Chimeric T Cell Receptor Possessing CD28 and CD137 Costimulatory Domains
2007
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Jinjuan Wang | 1529 | 641 | 65 | 545 | 32 | 1.8k | |
| Evripidis Lanitis | 1559 | 868 | 9 | 360 | 25 | 2.1k | |
| Qunrui Ye | 1416 | 1012 | 9 | 330 | 17 | 2.0k | |
| Barbara Camisa | 1692 | 1140 | 284 | 520 | 27 | 2.5k | |
| Jonathan Villena‐Vargas | 1570 | 603 | 8 | 362 | 38 | 2.1k | |
| Jean‐Baptiste Latouche | 1520 | 1199 | 6 | 524 | 47 | 2.3k | |
| Stefanie R. Bailey | 1549 | 1067 | 10 | 369 | 34 | 2.2k | |
| Zeguo Zhao | 1480 | 863 | 5 | 465 | 21 | 2.0k | |
| Armin Ehninger | 1276 | 643 | 12 | 384 | 42 | 2.3k | |
| Christel Devaud | 1346 | 987 | 10 | 322 | 26 | 1.8k | |
| Terence J. Purdon | 2752 | 1086 | 4 | 826 | 41 | 3.0k |
All Works
Login with ORCID to disown or claim papers
Loading papers...